All In Biotech

Drug Trial Radar · NCT05680818

Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1

CALIBRATE: A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)

Last checked: Nov 20, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

67

Actual

Start

Jan 6, 2023

Primary completion

Aug 22, 2025

Study completion Aug 2029

Sponsor

Sponsor type
Industry
First posted
Jan 11, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 16 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of the study is to understand the effectiveness, safety, and tolerability of encaleret when compared to standard of care (SoC) treatment in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1).

Conditions

  • Autosomal Dominant Hypocalcemia (ADH)

Interventions

  • EncaleretDrug

    Administered as film-coated tablet for oral use

  • Standard of CareDietary supplement

    Calcium supplements and/or active Vitamin D (calcitriol, alfacalcidol, falecalcitriol, etc.)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Responders who Achieve Both Albumin-Corrected Blood Calcium (cCa) and 24-hour Urinary Calcium (UCa) Within the Target RangeTime frame: Up to Week 24

Locations

25 sites in 10 countries. Site status is shown where the registry gives one.

  • UCSF Benioff Children's Hospital, Oakland

    Oakland, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • Indiana University Health University Hospital

    Indianapolis, Indiana

  • NIH

    Bethesda, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Mayo Clinic - Rochester

    Rochester, Minnesota

  • Columbia University Irving Medical Center

    New York, New York

  • Physicians East

    Greenville, North Carolina

  • Ohio State University Medical Center

    Columbus, Ohio

  • The Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • Houston Methodist Hospital

    Houston, Texas

  • Royal North Shore Hospital

    Saint Leonards, New South Wales, Australia

  • Royal Brisbane and Women's Hospital

    Herston, Queensland, Australia

  • Bone Research & Education Centre

    Oakville, Ontario, Canada

  • Vseobecna fakultni nemocnice v Praze

    New Town, Czechia

  • Aarhus University Hospital

    Aarhus, Denmark

  • Hôpital Edouard Herriot - HCL

    Lyon, France

  • CHU Bicetre

    Le Kremlin-Bicêtre, Le Kremlin-Bicêtre, France

  • IRCCS Ospedale San Raffaele

    Milan, Italy

  • University Hospital of Pisa

    Pisa, Italy

  • Fondazione Policlinico Universitario Campus Bio-Medico

    Roma, Italy

  • The University of Tokyo Hospital

    Tokyo, Japan

  • Eramus MC

    Rotterdam, Netherlands

  • Freeman Hospital

    Newcastle upon Tyne, United Kingdom

  • Norfolk and Norwich University Hospital

    Norwich, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.